PubMed ID: 21831374 Author(s): Zhong W, Cruickshanks KJ, Huang GH, Klein BE, Klein R, Nieto FJ, Pankow JS, Schubert CR. Carotid atherosclerosis and cognitive function in midlife: the Beaver Dam Offspring Study. Atherosclerosis. 2011 Nov;219(1):330-3. …
eyes
Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis.
PubMed ID: 21398363 Author(s): Awua-Larbi S, Wong TY, Cotch MF, Durazo-Arvizu R, Jacobs DR Jr, Klein BE, Klein R, Lima J, Liu K, Kramer H. Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study …
Clinical evidence for neuroprotection in glaucoma.
PubMed ID: 22017839 Author(s): Cordeiro MF, Levin LA. Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol. 2011 Nov;152(5):715-6. doi: 10.1016/j.ajo.2011.06.015. PMID 22017839 Journal: American Journal Of Ophthalmology, Volume 152, Issue 5, Nov 2011
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
PubMed ID: 21862954 Author(s): Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups. Oral protein kinase c β inhibition using ruboxistaurin: …
Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
PubMed ID: 21659941 Author(s): Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 2011 Nov;31(10):2032-6. doi: 10.1097/IAE.0b013e31820f4b4f. PMID 21659941 Journal: Retina (Philadelphia, Pa.), Volume 31, Issue 10, …
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.
PubMed ID: 21839131 Author(s): Jones JC, Settles EW, Brandt CR, Schultz-Cherry S. Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine. Vaccine. 2011 Oct 13;29(44):7696-703. doi: 10.1016/j.vaccine.2011.07.133. Epub 2011 Aug 10. PMID 21839131 …
Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.
PubMed ID: 21972262 Author(s): Weinreb RN, Kaufman PL. Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol …
Modifiable determinants of hearing impairment in adults.
PubMed ID: 21871479 Author(s): Zhan W, Cruickshanks KJ, Klein BE, Klein R, Huang GH, Pankow JS, Gangnon RE, Tweed TS. Modifiable determinants of hearing impairment in adults. Prev Med. 2011 Oct;53(4-5):338-42. doi: 10.1016/j.ypmed.2011.08.012. Epub 2011 …
The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.
PubMed ID: 21492158 Author(s): Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, Saaddine JB; Vision Cost-Effectiveness Study Group. The cost-effectiveness of three screening alternatives for people with diabetes with no or …